StageZero Life Sciences Ltd. — Audit Report / Information 2024

Apr 23, 2025

EY

Ernst & Young LLP

Suite 500

725 South Figueroa Street

Los Angeles, CA 90017-5418

Tel: +1 213 977 3200

Fax: +1 213 977 3152

ey.com

Shape the future with confidence

April 22, 2025

Alberta Securities Commission
Autorité des marchés financiers (Québec)
British Columbia Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Financial and Consumer Services Commission (New Brunswick)
Nova Scotia Securities Commission
Office of the Superintendent of Securities (Prince Edward Island)
Office of the Superintendent of Securities Service Newfoundland and Labrador
Ontario Securities Commission
The Manitoba Securities Commission

Dear Sirs / Mesdames:

Re: Brookfield Asset Management Ltd.

We refer to the prospectus supplement of Brookfield Asset Management Ltd. (the "Company") dated April 22, 2025 relating to the sale and issue of notes (the "Prospectus").

We consent to being named and to the use, through incorporation by reference in the Prospectus, of our report dated March 17, 2025 to the unitholders of Oaktree Capital II, L.P., Oaktree Capital Management, L.P., Oaktree AIF Investments, L.P., Oaktree Capital Management (Cayman), L.P., and Oaktree Investment Holdings, L.P. and their consolidated subsidiaries (collectively, the "Oaktree Asset Management Operating Group") on the following financial statements of the Oaktree Asset Management Operating Group included in the Company's Annual Report (Form 10-K) for the year ended December 31, 2024:

• Combined and consolidated statements of financial condition as of December 31, 2024 and 2023;
• Combined and consolidated statements of operations, comprehensive income, cash flows and changes in unitholders' capital for each of the three years in the period ended December 31, 2024, and the related notes.

We report that we have read the Prospectus and all information specifically incorporated by reference therein and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the financial statements upon which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditor's consent to the use of a report of the auditor included in an offering document, which does not constitute an audit or review of the Prospectus as these terms are described in the CPA Canada Handbook – Assurance.

Yours truly,

Ernst & Young LLP

A member firm of Ernst & Young Global Limited